---
document_datetime: 2023-09-21 21:35:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/livtencity-epar-all-authorised-presentations_en.pdf
document_name: livtencity-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6549717
conversion_datetime: 2025-12-17 15:36:48.368281
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                     | (Invented) name                  | Strength             | Pharmaceutical form                                      | Route of administration    | Immediate Packaging                       | Pack size                                  |
|----------------------------------------------------|----------------------------------|----------------------|----------------------------------------------------------|----------------------------|-------------------------------------------|--------------------------------------------|
| EU/1/22/1672/001 EU/1/22/1672/002 EU/1/22/1672/003 | LIVTENCITY LIVTENCITY LIVTENCITY | 200 mg 200 mg 200 mg | Film-coated tablet Film-coated tablet Film-coated tablet | Oral use Oral use Oral use | bottle (HDPE) bottle (HDPE) bottle (HDPE) | 28 tablets 56 tablets 112 (2 x 56) tablets |